RETINA READ RISK– November 2024. GENESIS BioMed’s Vision: Advancing Retina Read Risk for Better Eye Health
About Retina Read Risk Retina Read Risk was officially launched in 2022. The goal of this 3-year project is to develop hardware and software for a new vision-screening process for diabetic retinopathy that, compared to previously developed methods, is both safer for patients and less time-consuming for medical staff. Retina Read Risk is a multidisciplinary …